Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
medobiotin tabletter
hübner naturarzneimittel gmbh - tabletter
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
eltroxin 50 mikrogram tabletter
aspen pharma trading ltd. - levothyroxinnatrium - tabletter - 50 mikrogram
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
viant pulver til infusionsv?ske, opl?sning
orifarm a/s - alfa-tocopherol, all-rac-, ascorbinsyre, biotin, cholecalciferol, cyanocobalamin, dexpanthenol, folsyre, nicotinamid, phytomenadion, pyridoxinhydrochlorid, retinolpalmitat, riboflavinnatriumphosphathydrat, thiaminhydrochlorid - pulver til infusionsvæske, opløsning
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
eltroxin 100 mikrogram tabletter
aspen pharma trading ltd. - levothyroxinnatrium - tabletter - 100 mikrogram
Európska únia -
dánčina -
EMA (European Medicines Agency)
ceprotin
takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antitrombotiske midler - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
esomeprazol "sun" 40 mg pulver til injektions-/infusionsvæske, opløsning
sun pharmaceutical industries europe bv - esomeprazolnatrium - pulver til injektions-/infusionsvæske, opløsning - 40 mg
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
dolenio 1,178 mg filmovertrukne tabletter
blue bio pharmaceuticals ltd. - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 1,178 mg
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
alendronat/cholecalciferol "bgr" 70 mg+140 mikrogram tabletter
biogaran - cholecalciferol, natriumalendronattrihydrat - tabletter - 70 mg+140 mikrogram
Dánsko -
dánčina -
Lægemiddelstyrelsen (Danish Medicines Agency)
alendronat/cholecalciferol "bgr" 70 mg+70 mikrogram tabletter
biogaran - cholecalciferol, natriumalendronattrihydrat - tabletter - 70 mg+70 mikrogram
Európska únia -
dánčina -
EMA (European Medicines Agency)
evista
substipharm - raloxifenhydrochlorid - osteoporose, postmenopausale - køn hormoner og modulatorer af den genitale system, - evista er indiceret til behandling og forebyggelse af osteoporose hos postmenopausale kvinder. en signifikant reduktion i forekomsten af vertebrale, men ikke hoftefrakturer er blevet påvist. when determining the choice of evista or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.